Regulatory considerations in biosimilars: Asia pacific regions. | Prep Biochem Biotechnol;51(1): 1-8, 2021. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Regulatory considerations in biosimilars: Asia pacific regions.

Rathore, Anurag S; Bhargava, Ankita.

Affiliation

Rathore AS; Department of Chemical Engineering, Indian Institute of Technology, Delhi, India.
Bhargava A; Department of Chemical Engineering, Indian Institute of Technology, Delhi, India.

Prep Biochem Biotechnol ; 51(1): 1-8, 2021.

Article in En | MEDLINE | ID: mdl-32921222

Subject(s)
Key words

Approved status; Asia Pacific biosimilars; key players; market size; regulatory framework

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Approval / Drug Industry / Biosimilar Pharmaceuticals Limits: Humans Country/Region as subject: Asia Language: En Journal: Prep Biochem Biotechnol Journal subject: BIOQUIMICA / BIOTECNOLOGIA Year: 2021 Document type: Article Affiliation country: India

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Approval / Drug Industry / Biosimilar Pharmaceuticals Limits: Humans Country/Region as subject: Asia Language: En Journal: Prep Biochem Biotechnol Journal subject: BIOQUIMICA / BIOTECNOLOGIA Year: 2021 Document type: Article Affiliation country: India